Blogs | Multibagger Shares

March 16, 2026

Hero Section Article Title About Rupee Until ₹93$ Subtitle in Italics Includes a Horizontal Bar Chart Showing Fy20fy25 Values with the Final Bar Highlighted in Green 11 in Fy25

Rupee at ₹93/$ — Why This Is a Golden Opportunity for Pharma & Biotech Investors

The Indian Rupee has depreciated to ~93 per US Dollar. While headlines scream doom, smart investors see this as a powerful tailwind for India's $30B+ pharma export engine. India is the Pharmacy of the World — and a weaker rupee makes it even more competitive. Here's why pharma & biotech stocks are the biggest beneficiaries.

March 16, 2026

Hero Header with the Title economic Moats and Green Subtitle on a Dark Blue Background a Two by two Color Block Grid Labeled Trader gray Compunder green Drift light Gray Speculator orange Footer Credit Text

Economic Moats: How to Find Companies That Competitors Simply Cannot Destroy

📅 Published March 16, 2026 (Monday) Table of Contents Toggle What Is an Economic Moat? The Five Types of Economic Moats 1. Cost Advantage Moat 2. […]

March 15, 2026

Hero Title How Titan Biotech Turned ₹1 Lakh with a Subtitle About Audited Fy25 Numbers and Shares Growth illustrative Article Header

How Titan Biotech Turned ₹1 Lakh into ₹50 Lakh — A Value Investing Case Study

Learn how Titan Biotech (BSE:524717) turned ₹1 Lakh into ₹50 Lakh — a real 50x multibagger case study with a 7-step value investing framework by Manish Goel, SEBI Registered Investment Advisor.

March 15, 2026

Infographic Titled the Piotroski F score with a 6 year Bar Chart of Financial Scores fy20fy25 Showing Values from 11 to 32 and a Green Fy25 Bar

The Piotroski F-Score: A 9-Point Checklist That Separates Multibaggers from Value Traps

📅 Published March 15, 2026 (Sunday) Table of Contents Toggle 🎯 Titan Biotech Ltd (BSE: 524717) — Snapshot What Is the Piotroski F-Score? Why the F-Score […]